top of page
  • Writer's pictureARQon

Europe - May 2020

  • Denmark: New rules mean non-serious adverse events may also need to be reported

  • EU: Application of Regulation (EU) 2017/745 postponed by one year

  • EU: Continued use of lead as a thermal stabiliser in PVC as a base material in certain IVDs

  • EU: Amendments to the Common Technical Specifications for IVDs

  • EU: Three new and three revised guidance documents issued by the MDCG

  • EU: Joint implementation and preparedness plan for the MDR

  • EU: Publication of new list of harmonised European standards

  • Finland: National legislation drafted to support implementation of EU Regulations

  • France: Distribution agreements must be in place by 1 January 2021

  • Ireland: Guidance on applying for Certificates of Free Sale has been updated

  • Spain: PMPS to finally close in May 2020

  • UK: MHRA fees unchanged for 2020/2021

  • UK: ‘Medicines and Medical Devices Bill 2019–21’

  • UK: Help for UK companies affected by closure or scope reduction of their Notified Body

  • UK: Updated guidance explains process for determining when clinical investigation is necessary


Click here for the full article on Global Regulatory Press.

Contact us at info@arqon.com

16 views0 comments

Recent Posts

See All

EU: MDR delayed to 26 May 2021

Application of the Medical Devices Regulation (MDR) has been deferred by one year, until 26 May 2021, for fear of shortage or delay in getting essential medical devices needed to combat Covid-19. The

EU 2020 MDR Guidance Notes For Class I Manufacturers

There will be no transition period for Class I medical devices which remain in Class I under MDR. From 26th May 2020 onwards, the conformity for Class I medical devices which are not subject to up-cla

EU: Symbols Guidance for MDR

To comply with new MDR requirements in an efficient manner before the relevant international standard is available, MedTech Europe publishes its guidance on graphical symbols to be used on medical dev

bottom of page